Luminex Debt to Equity Ratio 2006-2019 | LMNX

Current and historical debt to equity ratio values for Luminex (LMNX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Luminex debt/equity for the three months ending September 30, 2019 was 0.04.
Luminex Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-09-30 $0.02B $0.46B 0.04
2019-06-30 $0.02B $0.47B 0.04
2019-03-31 $0.02B $0.47B 0.04
2018-12-31 $0.00B $0.47B 0.00
2018-09-30 $0.00B $0.47B 0.00
2018-06-30 $0.00B $0.47B 0.00
2018-03-31 $0.00B $0.46B 0.00
2017-12-31 $0.00B $0.44B 0.00
2017-09-30 $0.00B $0.44B 0.00
2017-06-30 $0.00B $0.42B 0.00
2017-03-31 $0.00B $0.41B 0.00
2016-12-31 $0.00B $0.40B 0.00
2016-09-30 $0.00B $0.40B 0.00
2016-06-30 $0.00B $0.40B 0.00
2016-03-31 $0.00B $0.38B 0.00
2015-12-31 $0.00B $0.37B 0.00
2015-09-30 $0.00B $0.34B 0.00
2015-06-30 $0.00B $0.33B 0.00
2015-03-31 $0.00B $0.33B 0.00
2014-12-31 $0.00B $0.32B 0.00
2014-09-30 $0.00B $0.30B 0.00
2014-06-30 $0.00B $0.29B 0.00
2014-03-31 $0.00B $0.28B 0.00
2013-12-31 $0.00B $0.27B 0.00
2013-09-30 $0.00B $0.26B 0.00
2013-06-30 $0.00B $0.25B 0.00
2013-03-31 $0.00B $0.25B 0.01
2012-12-31 $0.00B $0.26B 0.01
2012-09-30 $0.00B $0.25B 0.01
2012-06-30 $0.00B $0.26B 0.01
2012-03-31 $0.00B $0.25B 0.01
2011-12-31 $0.00B $0.25B 0.01
2011-09-30 $0.00B $0.25B 0.01
2011-06-30 $0.00B $0.25B 0.01
2011-03-31 $0.00B $0.24B 0.01
2010-12-31 $0.00B $0.24B 0.01
2010-09-30 $0.00B $0.23B 0.02
2010-06-30 $0.00B $0.23B 0.02
2010-03-31 $0.00B $0.22B 0.02
2009-12-31 $0.00B $0.22B 0.02
2009-09-30 $0.00B $0.20B 0.02
2009-06-30 $0.00B $0.20B 0.02
2009-03-31 $0.00B $0.19B 0.02
2008-12-31 $0.00B $0.20B 0.02
2008-09-30 $0.00B $0.19B 0.02
2008-06-30 $0.00B $0.18B 0.02
2008-03-31 $0.00B $0.10B 0.03
2007-12-31 $0.00B $0.10B 0.03
2007-09-30 $0.00B $0.09B 0.03
2007-06-30 $0.00B $0.09B 0.04
2007-03-31 $0.00B $0.10B 0.03
2006-12-31 $0.00B $0.05B 0.00
2006-09-30 $0.00B $0.05B 0.00
2006-06-30 $0.00B $0.05B 0.00
2006-03-31 $0.00B $0.05B 0.00
2005-12-31 $0.00B $0.05B 0.00
2005-09-30 $0.00B $0.05B 0.00
2005-06-30 $0.00B $0.05B 0.00
2005-03-31 $0.00B $0.05B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.900B $0.316B
Luminex Corporation is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP open-architecture, multi-analyte platform and MultiCode real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $120.694B 25.00
Intuitive Surgical (ISRG) United States $65.772B 51.69
Edwards Lifesciences (EW) United States $50.553B 45.90
IDEXX Laboratories (IDXX) United States $22.349B 54.05
Fresenius Medical Care AG KGaA (FMS) Germany $22.319B 15.10
Olympus (OCPNY) Japan $21.117B 158.58
DexCom (DXCM) United States $19.567B 175.23
Teleflex (TFX) United States $15.957B 32.40
SONOVA HOLDING (SONVY) Switzerland $15.349B 0.00
Sysmex ADR (SSMXY) Japan $14.543B 39.15
STERIS (STE) Ireland $12.665B 27.97
Hologic (HOLX) United States $12.502B 19.17
Varian Medical Systems (VAR) United States $11.736B 27.78
ABIOMED (ABMD) United States $8.042B 43.76
Masimo (MASI) United States $7.994B 47.73
Penumbra (PEN) United States $5.813B 189.19
SARTORIUS AG (SARTF) Germany $5.614B 49.28
Globus Medical (GMED) United States $5.478B 33.81
Integra LifeSciences Holdings (IART) United States $4.982B 21.41
Elekta AB (EKTAY) Sweden $4.800B 36.96
LivaNova (LIVN) United Kingdom $3.790B 27.29
Wright Medical Group (WMGI) Netherlands $3.737B 226.54
Tandem Diabetes Care (TNDM) United States $3.730B 0.00
Nevro (NVRO) United States $3.244B 0.00
Cantel Medical (CMD) United States $3.036B 30.09
Integer Holdings (ITGR) United States $2.395B 16.40
Nihon Kohden (NHNKY) Japan $2.365B 23.79
Glaukos (GKOS) United States $2.238B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.566B 30.82
Inogen (INGN) United States $1.532B 48.38
Veracyte (VCYT) United States $1.243B 0.00
Silk Road Medical (SILK) United States $1.158B 0.00
Tactile Systems Technology (TCMD) United States $1.087B 124.22
Natus Medical (NTUS) United States $1.072B 25.78
Mesa Laboratories (MLAB) United States $1.013B 37.54
OPKO Health (OPK) United States $0.985B 0.00
CryoLife (CRY) United States $0.924B 94.77
Accelerate Diagnostics (AXDX) United States $0.886B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.857B 28.47
Pacific Biosciences Of California (PACB) United States $0.710B 0.00
Intersect ENT (XENT) United States $0.665B 0.00
AxoGen (AXGN) United States $0.616B 0.00
OrthoPediatrics (KIDS) United States $0.578B 0.00
AngioDynamics (ANGO) United States $0.568B 20.39
Quotient (QTNT) Switzerland $0.546B 0.00
Alphatec Holdings (ATEC) United States $0.452B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.442B 13.38
Si-Bone (SIBN) United States $0.439B 0.00
Sientra (SIEN) United States $0.392B 0.00
GenMark Diagnostics (GNMK) United States $0.321B 0.00
Semler Scientific (SMLR) United States $0.287B 40.00
ViewRay (VRAY) United States $0.277B 0.00
IRadimed (IRMD) United States $0.265B 37.27
Stereotaxis (STXS) United States $0.250B 0.00
SeaSpine Holdings (SPNE) United States $0.248B 0.00
Accuray (ARAY) United States $0.239B 0.00
CRH Medical (CRHM) Canada $0.215B 60.00
Fluidigm (FLDM) United States $0.162B 0.00
EDAP TMS S.A (EDAP) France $0.143B 38.00
RTI Surgical (RTIX) United States $0.143B 38.80
ConforMIS (CFMS) United States $0.121B 0.00
Second Sight Medical Products (EYES) United States $0.107B 0.00
Spectral Diagnostics (EDTXF) Canada $0.095B 0.00
Electromed (ELMD) United States $0.084B 29.97
T2 Biosystems (TTOO) United States $0.078B 0.00
Neuronetics (STIM) United States $0.078B 0.00
Vermillion (VRML) United States $0.075B 0.00
TransEnterix (TRXC) United States $0.066B 0.00
Sensus Healthcare (SRTS) United States $0.058B 0.00
Apollo Endosurgery (APEN) United States $0.058B 0.00
Bioanalytical Systems (BASI) United States $0.054B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.041B 0.00
Ekso Bionics Holdings (EKSO) United States $0.039B 0.00
Xtant Medical Holdings (XTNT) United States $0.026B 0.00
Neovasc (NVCN) Canada $0.022B 0.00
Ra Medical Systems (RMED) United States $0.020B 0.00
Helius Medical Technologies (HSDT) United States $0.019B 0.00
ReWalk Robotics (RWLK) Israel $0.015B 0.00
OBALON THERPTCS (OBLN) United States $0.013B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.013B 0.00
Nanovibronix (NAOV) United States $0.013B 0.00
Avinger (AVGR) United States $0.011B 0.00
DarioHealth (DRIO) Israel $0.009B 0.00
Lianluo Smart (LLIT) China $0.009B 0.00
Restoration Robotics (VERO) Canada $0.009B 0.00
ENDRA Life Sciences (NDRA) United States $0.007B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
Dynatronics (DYNT) United States $0.007B 0.00
Viveve Medical (VIVE) United States $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Allied Healthcare Products (AHPI) United States $0.004B 0.00
Nuvectra (NVTR) United States $0.003B 0.00
Sunshine Heart Inc (CHFS) United States $0.002B 0.00
InspireMD (NSPR) Israel $0.001B 0.00